MediJane Holdings (OTCQB: MJMD) has its principal executive offices in Longmont and is led by president Ronald Lusk.
MediJane is in the business of marketing and distributing products within the medicinal-marijuana industry, including transdermal patches, capsules, sublingual sprays and other medical delivery systems.
Cohen has developed an approach to wellness that combines functional medicine with the use of natural substances, such as medicinal cannabis.
“I’m absolutely thrilled to be involved in a project that I’m so passionate about,” Cohen said in a prepared statement. “This industry is on the cusp of fantastic new medical breakthroughs and I’m proud to be working with MediJane to do our part to ensure the long-term sustainability of medical delivery systems for the safe and legal access to medical marijuana.”
In the 1990s, Cohen practiced obstetrics and gynecology initially with the Boulder Women’s Clinic and then formed Full Circle Health Associates, a group that combined conventional and integrative medicine. During that time. Cohen was both the medical director of the Center for Integrative Therapeutics at Longmont United Hospital, as well as department chairman in OB/GYN and pediatrics.
In 2001, Cohen left Colorado and began working with women from several different cultures. This included Hispanic women at The Medical Center of Aurora where he worked as a hospitalist, Native American women in Wyoming (Arapaho and Shoshoni tribes) and Maori women in Whanganui, New Zealand.
During the past decade he has been studying functional medicine. Since returning to Boulder from New Zealand in 2009, he has integrated medical marijuana into his holistic functional medicine practice.
MediJane has sales offices opening in California and Colorado, and a planned expansion into a national footprint.
Last month, MediJane, formerly named Mokita Inc., entered a license agreement with Phoenix Bio Pharmaceuticals Corp., a Colorado-based developer of medicinal cannabinoid products and delivery systems for the treatment and management of illnesses. MediJane, through a stock transaction, acquired an exclusive North American license for all intellectual property, processes and expertise related to certain medicinal cannabinoid products and delivery systems developed by Phoenix Bio Pharm and its team.